Skip to content

Assist Control Versus Pressure Support Modes for Domiciliary Noninvasive Ventilation in Chronic Respiratory Failure

Assist Control Versus Pressure Support Modes for Domiciliary Noninvasive Ventilation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00189527
Enrollment
100
Registered
2005-09-19
Start date
2006-01-31
Completion date
2009-10-31
Last updated
2011-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Respiratory Failure

Brief summary

Noninvasive ventilation is a therapeutic option in some patients with chronic respiratory failure. Patients usually ventilate during nightime with a domiciliary ventilator either in assist control or in pressure support mode. The aim of this study is to compare the clinical efficacy and the tolerance of assist control and pressure support modes during domiciliary noninvasive ventilation in patients with chronic respiratory failure.

Detailed description

The aim of this study is to compare the clinical efficacy and the tolerance of assist control and pressure support modes during domiciliary noninvasive ventilation in patients with chronic respiratory failure.

Interventions

PROCEDURErespiratory settings

Sponsors

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic respiratory failure * Clinical symptoms of chronic alveolar hypoventilation * PaCO2 ≥ 45 mmHg in case of restrictive pulmonary disorder or PaCO2 ≥ 55 mmHg in case or obstructive pulmonary disorder

Exclusion criteria

* Clinical exacerbation during the three previous weeks * Previous treatment by domiciliary non invasive ventilation * Previous treatment by non invasive ventilation for acute respiratory failure during the 3 previous months * Bronchiectasis * Duchenne muscular dystrophy * Amyotrophic lateral sclerosis

Design outcomes

Primary

MeasureTime frameDescription
PaO2monthsBlood gases response to ventilation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026